Evaluate the following inpatient scenarios involving patients currently receiving antimicrobial therapy. Match each clinical situation to the most appropriate stewardship-aligned modification to their regimen.
- A 70-year-old woman admitted with pyelonephritis and bacteremia, initially treated with empiric piperacillin-tazobactam. Cultures grow pan-susceptible Escherichia coli. She remains strictly NPO due to severe nausea.De-escalate to intravenous ceftriaxone.
- A 65-year-old man admitted for an acute exacerbation of chronic obstructive pulmonary disease (COPD), initially started on levofloxacin. On hospital day 2, his respiratory viral panel is positive for Influenza A, and his serum procalcitonin level is 0.04 ng/mL.Discontinue antibacterial therapy and begin oseltamivir.
- A 55-year-old man recovering from ventilator-associated pneumonia has received 8 days of appropriately targeted cefepime. He has been afebrile for 72 hours with normalized inflammatory markers and stable respiratory status.Discontinue antimicrobial therapy completely.
- A 40-year-old woman with community-acquired pneumonia initially treated with intravenous ceftriaxone and azithromycin. She is now afebrile, eating well, and her urinary pneumococcal antigen test returns positive.Transition to oral amoxicillin.
Cevap
The correct matches align specific stewardship principles to each scenario: de-escalating to narrow-spectrum intravenous therapy when oral intake is contraindicated, discontinuing antibiotics when a viral etiology is confirmed, adhering to evidence-based 7-day treatment durations for VAP, and transitioning to narrow-spectrum oral therapy when a patient demonstrates clinical stability.
Each correct pairing reflects a core pillar of antimicrobial stewardship: (1) tailoring therapy to the narrowest spectrum agent based on culture results, (2) stopping antibiotics when biomarkers and viral panels suggest an alternative etiology, (3) restricting therapy to guideline-recommended durations to limit toxicity, and (4) transitioning to oral agents to reduce hospital length of stay and line-associated complications once clinical stability is achieved.
Adım Adım Çözüm
Anahtar Kavram
Antimicrobial stewardship involves optimizing patient outcomes while minimizing resistance by de-escalating to the narrowest effective agent, converting from intravenous to oral routes upon clinical stability, limiting treatment to evidence-based durations, and discontinuing antibiotics when non-bacterial etiologies are identified.